What is it about?
To evaluate the safety and efficacy of cabergoline in men with erectile dysfunction (ED) who did not respond to sildenafil.
Photo by Catt Liu on Unsplash
Why is it important?
Sildenafil citrate, an orally administered phosphodiesterase-5 (PDE-5) inhibitor generally used to treat erectile dysfunction (ED). It is the first oral medication to exhibit significant and reliable efficacy in most patients with ED.1 Nowadays more than 15 million men have used this medication with primary care specialists writing more than half of these prescriptions
Read the Original
This page is a summary of: Salvage of sildenafil failures with cabergoline: a randomized, double-blind, placebo-controlled study, International Journal of Impotence Research, April 2006, Springer Science + Business Media, DOI: 10.1038/sj.ijir.3901476.
You can read the full text:
The following have contributed to this page